- Home
- MYN vs NRC Comparison
MYN vs NRC Comparison
Compare MYN & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYN | NRC |
|---|---|---|
| Founded | 1992 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 380.8M | 428.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MYN | NRC |
|---|---|---|
| Price | $10.02 | $12.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 86.0K | ★ 123.8K |
| Earning Date | 01-01-0001 | 02-03-2026 |
| Dividend Yield | 4.12% | ★ 4.99% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.50 |
| Revenue | N/A | ★ $137,390,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $25.66 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.47 | $9.76 |
| 52 Week High | $10.62 | $22.79 |
Technical Indicators
Market Signals| Indicator | MYN | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 27.32 |
| Support Level | $9.96 | $12.65 |
| Resistance Level | $10.15 | $16.45 |
| Average True Range (ATR) | 0.11 | 1.48 |
| MACD | -0.00 | -0.80 |
| Stochastic Oscillator | 34.38 | 3.01 |
Price Performance
Historical ComparisonAbout MYN Blackrock MuniYield New York Quality Fund Inc.
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.